29.10.2013 Views

Abstracts - Chirurgie Kongress

Abstracts - Chirurgie Kongress

Abstracts - Chirurgie Kongress

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

lower pulmonary vein. Staging showed no other tumor manifestations. After an unsuccesfull CT-guided<br />

biopsy, a thoracotomy with lobectomy of the lower lobe and mediastinal lymphadenectomy was<br />

performed. Postoperatively, the patient developed a left sided hemiplegia of arm and leg. A CT scan<br />

of the brain showed ischemic areas, likely due to tumor emboli. Meanwhile, a new CT-Scan reveiled<br />

tumor progression along the left lung vein into the left atrium. The patient was transferred to a tertiary<br />

center for subsequent surgery with extirpation of the residuary tumor. The patient recovered very well<br />

and went on to receive additive chemotherapy for 6 months. Currently there is no evidence of disease<br />

recurrence and the patient continues regular follow-up.<br />

Conclusion: The patient has recovered completely from the cerebral embolism, the surgery and the<br />

chemotherapy. The further outcome remains uncertain. According to the literature, outcome is poor<br />

in patients with metastatic disease. However, in cases of successful local resection, longterm survival<br />

has been reported.<br />

83.4<br />

Oral anticoagulation in aortic dissection: Effect on secondary dilatation and malperfusion syndrome<br />

E. Krähenbühl, S. Prader, F. Immer, E. Krähenbühl, L. Englberger, D. Reineke, T. Carrel, J. Schmidli<br />

(Bern)<br />

Introduction: Late complications are frequently encountered in patients treated because of acute type<br />

A dissection (AADA). Secondary dilatation and immediate or delayed malperfusion syndrome (MPS)<br />

are the most common complications. The effect of oral anticoagulation (OA) following AADA repair is<br />

discussed controversially. No guidelines are available in the literature.<br />

Methods: 108 patients who underwent AADA repair were analyzed. 59 patients (54.6%) were under<br />

antiplatelets (AP) and 32 (29.6%) under cumadine (OA). The remaining patients had no medication<br />

or a combination of both treatments. Follow-up data were analyzed, focusing on patency of the false<br />

lumen, the occurrence of delayed MPS and late dilatation. Results were compared between the two<br />

groups.<br />

Results: Patients characteristics were similar in both groups. Average follow-up was 31.1±14.2 months.<br />

Secondary dilatation was more pronounced in the AP-group with an overall average increase per patient<br />

of 0.4mm/y compared to 0.02mm/y in the OA-group (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!